Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/194715
Full metadata record
DC FieldValueLanguage
dc.contributor.CRUESPUNIVERSIDADE DE ESTADUAL DE CAMPINASpt_BR
dc.typeArtigo de periódicopt_BR
dc.titleInvolvement Of Vanilloid Receptors And Purinoceptors In The Phoneutria Nigriventer Spider Venom-induced Plasma Extravasation In Rat Skin.pt_BR
dc.contributor.authorCosta, S Kpt_BR
dc.contributor.authorDe Nucci, Gpt_BR
dc.contributor.authorAntunes, Ept_BR
dc.contributor.authorBrain, S Dpt_BR
unicamp.authorS K Costa, Department of Pharmacology, Faculty of Medical Sciences, UNICAMP, 13081-970, Campinas, Brazil.pt_BR
unicamp.author.externalG De Nucci,pt
unicamp.author.externalE Antunes,pt
unicamp.author.externalS D Brain,pt
dc.subjectAnimalspt_BR
dc.subjectBlood Proteinspt_BR
dc.subjectCapillary Permeabilitypt_BR
dc.subjectCapsaicinpt_BR
dc.subjectFemalept_BR
dc.subjectHistaminept_BR
dc.subjectMalept_BR
dc.subjectMast Cellspt_BR
dc.subjectNeurons, Afferentpt_BR
dc.subjectNeuropeptidespt_BR
dc.subjectNucleotidespt_BR
dc.subjectPeritoneal Cavitypt_BR
dc.subjectRatspt_BR
dc.subjectRats, Wistarpt_BR
dc.subjectReceptors, Drugpt_BR
dc.subjectReceptors, Purinergicpt_BR
dc.subjectSerotoninpt_BR
dc.subjectSpider Venomspt_BR
dc.description.abstractPhoneutria nigriventer venom causes stimulation of capsaicin-sensitive primary afferent neurons in the rat dorsal skin, leading to neurogenic plasma protein extravasation due to the release of tachykinin NK(1) receptor agonist. In this study we further investigated the mechanisms involved in the venom-induced activation of capsaicin-sensitive primary afferent neurons. The plasma extravasation in response to venom intradermally injected was measured in Wistar rats as the local accumulation of i.v. injected 125I-labelled human serum albumin into skin sites. The tachykinin NK(1) receptor agonist, D-Ala-[L-Pro(9),Me-Leu(8)]substance P-(7-11) (GR73632; 10-100 pmol/site), induced a significant plasma leakage that was abolished by the selective tachykinin NK(1) receptor antagonist, (S)-1-[2-[3-(3,4-dichlorphenyl)-1 (3-isopropoxyphenylacetyl) piperidin-3-yl] ethyl]-4-phenyl-1 azaniabicyclo [2.2.2]octane chloride (SR140333; 1 nmol/site), whereas the leakage after venom (1-10 microgram/site) was significantly inhibited (but not abolished) by SR140333. The calcitonin gene-related peptide (CGRP) receptor antagonist, CGRP-(8-37), failed to further reduce the residual plasma extravasation induced by venom plus SR140333. The mu-opioid receptor agonist, [D-Ala(2), Me-Phe(4),Gly-ol(5)]enkephalin (DAMGO), and the local anaesthetic, lignocaine, had no effect on the venom-induced plasma extravasation. Similarly, the L-, N- and P/Q-type voltage-sensitive Ca(2+) channel blockers (verapamil, omega-conotoxin MVIIA and MVIIC, respectively) as well as the Na(+) channel blockers, tetrodotoxin and carbamazepine, had no effect on the venom-induced effect. Neither the systemic treatment nor the local injection of ruthenium red prevented the venom-induced plasma extravasation. However, the vanilloid receptor antagonist, N-[2-(4-chlorophenyl) ethyl]-1,3,4, 5-tetrahydro-7,8-dihydroxy-2H-2-benzazepine-2-carbothioamide (capsazepine; 120 micromol/kg, i.v.), reduced by 48% (P<0.05) the venom (10 microgram/site)-induced plasma extravasation. A significant inhibitory effect was also observed with the P(2) purinoceptor agonists, adenosine 5'-triphosphate (ATP; 10 and 30 nmol/site) and adenosine 5'-diphosphate (ADP; 10 nmol/site). The involvement of histamine and/or 5-hydroxytryptamine (5-HT) in the venom-induced plasma extravasation was ruled out since neither histamine and 5-HT receptor antagonists nor depletion of mast cells by compound 48/80 affected the venom response. This was further supported by the failure of venom to degranulate in vitro peritoneal mast cells. In conclusion, only vanilloid receptors and P(2) prejunctional purinoceptors had an inhibitory effect on the neurogenic plasma extravasation evoked by P. nigriventer venom in rat dorsal skin.en
dc.relation.ispartofEuropean Journal Of Pharmacologypt_BR
dc.relation.ispartofabbreviationEur. J. Pharmacol.pt_BR
dc.date.issued2000-Marpt_BR
dc.identifier.citationEuropean Journal Of Pharmacology. v. 391, n. 3, p. 305-15, 2000-Mar.pt_BR
dc.language.isoengpt_BR
dc.description.volume391pt_BR
dc.description.firstpage305-15pt_BR
dc.rightsfechadopt_BR
dc.sourcePubMedpt_BR
dc.identifier.issn0014-2999pt_BR
dc.identifier.urlhttp://www.ncbi.nlm.nih.gov/pubmed/10729373pt_BR
dc.date.available2015-11-27T12:22:55Z-
dc.date.accessioned2015-11-27T12:22:55Z-
dc.description.provenanceMade available in DSpace on 2015-11-27T12:22:55Z (GMT). No. of bitstreams: 1 pmed_10729373.pdf: 279050 bytes, checksum: 98de72a018ab90415b7a7db55970c8e6 (MD5) Previous issue date: 2000 Bitstreams deleted on 2020-05-18T20:40:50Z: pmed_10729373.pdf,. Added 1 bitstream(s) on 2020-05-19T14:30:33Z : No. of bitstreams: 1 10729373.pdf: 356218 bytes, checksum: d4edf254ee9755bd1541b052115932b0 (MD5)en
dc.identifier.urihttp://repositorio.unicamp.br/jspui/handle/REPOSIP/194715-
dc.identifier.idPubmed10729373pt_BR
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
10729373.pdf347.87 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.